127 related articles for article (PubMed ID: 31902977)
1. Molecular docking based virtual screening of the breast cancer target NUDT5.
Sultana R; Islam M; Haque MA; Evamoni FZ; Imran ZM; Khanom J; Munim MA
Bioinformation; 2019; 15(11):784-789. PubMed ID: 31902977
[TBL] [Abstract][Full Text] [Related]
2. Targeted NUDT5 inhibitors block hormone signaling in breast cancer cells.
Page BDG; Valerie NCK; Wright RHG; Wallner O; Isaksson R; Carter M; Rudd SG; Loseva O; Jemth AS; Almlöf I; Font-Mateu J; Llona-Minguez S; Baranczewski P; Jeppsson F; Homan E; Almqvist H; Axelsson H; Regmi S; Gustavsson AL; Lundbäck T; Scobie M; Strömberg K; Stenmark P; Beato M; Helleday T
Nat Commun; 2018 Jan; 9(1):250. PubMed ID: 29343827
[TBL] [Abstract][Full Text] [Related]
3. Cleavage of oxidized guanine nucleotide and ADP sugar by human NUDT5 protein.
Ito R; Sekiguchi M; Setoyama D; Nakatsu Y; Yamagata Y; Hayakawa H
J Biochem; 2011 Jun; 149(6):731-8. PubMed ID: 21389046
[TBL] [Abstract][Full Text] [Related]
4. Expression of Oncogenic Drivers in 3D Cell Culture Depends on Nuclear ATP Synthesis by NUDT5.
Pickup KE; Pardow F; Carbonell-Caballero J; Lioutas A; Villanueva-Cañas JL; Wright RHG; Beato M
Cancers (Basel); 2019 Sep; 11(9):. PubMed ID: 31510016
[TBL] [Abstract][Full Text] [Related]
5. Activation of NUDT5, an ADP-ribose pyrophosphatase, by nitric oxide-mediated ADP-ribosylation.
Yu HN; Song EK; Yoo SM; Lee YR; Han MK; Yim CY; Kwak JY; Kim JS
Biochem Biophys Res Commun; 2007 Mar; 354(3):764-8. PubMed ID: 17261271
[TBL] [Abstract][Full Text] [Related]
6. Identification of promising inhibitors against breast cancer disease by targeting NUDIX hydrolase 5 (NUDT5) biomolecule.
Almansour NM
J Biomol Struct Dyn; 2023 Dec; ():1-12. PubMed ID: 38063166
[TBL] [Abstract][Full Text] [Related]
7. Identification of NUDT5 Inhibitors From Approved Drugs.
Tong XY; Liao X; Gao M; Lv BM; Chen XH; Chu XY; Zhang QY; Zhang HY
Front Mol Biosci; 2020; 7():44. PubMed ID: 32300600
[TBL] [Abstract][Full Text] [Related]
8. Lowered nudix type 5 (NUDT5) expression leads to cell cycle retardation in HeLa cells.
Zhang LQ; Dai DP; Gan W; Takagi Y; Hayakawa H; Sekiguchi M; Cai JP
Mol Cell Biochem; 2012 Apr; 363(1-2):377-84. PubMed ID: 22200976
[TBL] [Abstract][Full Text] [Related]
9. Role of the NUDT Enzymes in Breast Cancer.
Wright RHG; Beato M
Int J Mol Sci; 2021 Feb; 22(5):. PubMed ID: 33668737
[TBL] [Abstract][Full Text] [Related]
10. Lowered Nudix type 5 expression leads to cellular senescence in IMR-90 fibroblast cells.
Zhang L; Song XN; Dai DP; Zhou XY; Gan W; Takagi Y; Hayakawa H; Sekiguchi M; Cai JP
Free Radic Res; 2013 Jul; 47(6-7):511-6. PubMed ID: 23581889
[TBL] [Abstract][Full Text] [Related]
11. Design, molecular docking, and molecular dynamics of thiourea-iron (III) metal complexes as NUDT5 inhibitors for breast cancer treatment.
Ruswanto R; Nofianti T; Mardianingrum R; Kesuma D; Siswandono
Heliyon; 2022 Sep; 8(9):e10694. PubMed ID: 36177227
[TBL] [Abstract][Full Text] [Related]
12. Single crystal XRD, DFT investigations and molecular docking study of 2- ((1,5-dimethyl-3-oxo-2-phenyl-2,3-dihydro-1H-pyrazol-4-yl)amino)naphthalene-1,4-dione as a potential anti- cancer lead molecule.
P R KR; Mary YS; Fernandez A; S AP; Mary YS; Thomas R
Comput Biol Chem; 2019 Feb; 78():153-164. PubMed ID: 30530296
[TBL] [Abstract][Full Text] [Related]
13. Mammalian enzymes for preventing transcriptional errors caused by oxidative damage.
Ishibashi T; Hayakawa H; Ito R; Miyazawa M; Yamagata Y; Sekiguchi M
Nucleic Acids Res; 2005; 33(12):3779-84. PubMed ID: 16002790
[TBL] [Abstract][Full Text] [Related]
14. Molecular mechanism of ADP-ribose hydrolysis by human NUDT5 from structural and kinetic studies.
Zha M; Guo Q; Zhang Y; Yu B; Ou Y; Zhong C; Ding J
J Mol Biol; 2008 Jun; 379(3):568-78. PubMed ID: 18462755
[TBL] [Abstract][Full Text] [Related]
15. Molecular dynamics study on conformational differences between dGMP and 8-oxo-dGMP: Effects of metal ions.
Fujiwara S; Sawada K; Amisaki T
J Mol Graph Model; 2014 Jun; 51():158-67. PubMed ID: 24929814
[TBL] [Abstract][Full Text] [Related]
16. Crystal structures of human NUDT5 reveal insights into the structural basis of the substrate specificity.
Zha M; Zhong C; Peng Y; Hu H; Ding J
J Mol Biol; 2006 Dec; 364(5):1021-33. PubMed ID: 17052728
[TBL] [Abstract][Full Text] [Related]
17. Selection of a GPER1 Ligand via Ligand-based Virtual Screening Coupled to Molecular Dynamics Simulations and Its Anti-proliferative Effects on Breast Cancer Cells.
Martínez-Muñoz A; Prestegui-Martel B; Méndez-Luna D; Fragoso-Vázquez MJ; García-Sánchez JR; Bello M; Martínez-Archundia M; Chávez-Blanco A; Dueñas-González A; Mendoza-Lujambio I; Trujillo-Ferrara J; Correa-Basurto J
Anticancer Agents Med Chem; 2018; 18(11):1629-1638. PubMed ID: 29745344
[TBL] [Abstract][Full Text] [Related]
18. Targeting poly(ADP-ribose) glycohydrolase to draw apoptosis codes in cancer.
Tanuma SI; Shibui Y; Oyama T; Uchiumi F; Abe H
Biochem Pharmacol; 2019 Sep; 167():163-172. PubMed ID: 31176615
[TBL] [Abstract][Full Text] [Related]
19. Virtual Screening for Potential Inhibitors of High-Risk Human Papillomavirus 16 E6 Protein.
Kumar S; Jena L; Mohod K; Daf S; Varma AK
Interdiscip Sci; 2015 Jun; 7(2):136-42. PubMed ID: 26199214
[TBL] [Abstract][Full Text] [Related]
20. Crystal structure-based discovery of a novel synthesized PARP1 inhibitor (OL-1) with apoptosis-inducing mechanisms in triple-negative breast cancer.
Fu L; Wang S; Wang X; Wang P; Zheng Y; Yao D; Guo M; Zhang L; Ouyang L
Sci Rep; 2016 Dec; 6(1):3. PubMed ID: 28442756
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
